clavulanic acid has been researched along with Tuberculosis, Pulmonary in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (28.57) | 18.2507 |
2000's | 3 (42.86) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ahuja, V; Balasubramanian, V; Balganesh, M; Bhattacharjee, D; Dinesh, N; Ganguly, S; Kumar, N; Panduga, V; Parab, M; Ramachandran, V; Reddy, J; Shandil, R; Sharma, S; Solapure, S; Vishwas, KG | 1 |
Clumeck, N; De Wit, S; Martin, C; Muylle, I; Payen, MC; Sergysels, R; Van Laethem, Y | 1 |
Dinçer, I; Ergin, A; Kocagöz, T | 1 |
Chambers, HF; Hopewell, PC; Kocagöz, T; Sipit, T; Turner, J | 1 |
Asseray, N; Desurmont, I; Dewailly, P; Fauchais, AL; Puisieux, F; Savage, C; Senneville, E | 1 |
González-Lahoz, JM; Laguna, F; Moreno, V; Valencia, ME | 1 |
Berger, J; Cofsky, R; Nadler, JP; Nord, JA; Saxena, M | 1 |
1 trial(s) available for clavulanic acid and Tuberculosis, Pulmonary
Article | Year |
---|---|
Activity of amoxicillin/clavulanate in patients with tuberculosis.
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Antitubercular Agents; Clavulanic Acid; Drug Therapy, Combination; Humans; Mycobacterium tuberculosis; Sputum; Tuberculosis, Pulmonary | 1998 |
6 other study(ies) available for clavulanic acid and Tuberculosis, Pulmonary
Article | Year |
---|---|
In vitro and in vivo efficacy of β-lactams against replicating and slowly growing/nonreplicating Mycobacterium tuberculosis.
Topics: Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Bacterial Agents; beta-Lactams; Clavulanic Acid; Disease Models, Animal; Drug Therapy, Combination; Female; Humans; Meropenem; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Streptomycin; Thienamycins; Treatment Outcome; Tuberculosis, Pulmonary | 2013 |
Clinical use of the meropenem-clavulanate combination for extensively drug-resistant tuberculosis.
Topics: Adolescent; Adult; Antitubercular Agents; Clavulanic Acid; Drug Therapy, Combination; Extensively Drug-Resistant Tuberculosis; Female; Humans; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Salvage Therapy; Severity of Illness Index; Thienamycins; Treatment Outcome; Tuberculosis, Pulmonary; Young Adult | 2012 |
The vitro efficacy of beta-lactam and beta-lactamase inhibitors against multidrug resistant clinical strains of Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Clavulanic Acid; Culture Media; Drug Resistance, Multiple, Bacterial; Enzyme Inhibitors; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2004 |
[Atypical presentation of tuberculosis in the elderly: a case report of pleuropericarditis].
Topics: Aged; Amoxicillin; Clavulanic Acid; Diagnosis, Differential; Drug Therapy, Combination; Female; Humans; Pericarditis; Pleural Effusion; Pleurisy; Roxithromycin; Tuberculosis, Pulmonary | 2000 |
[Multiresistant tuberculosis caused by Mycobacterium bovis and human immunodeficiency virus infection. Are there new therapeutic possibilities?].
Topics: Acetamides; Adult; AIDS-Related Opportunistic Infections; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Antiretroviral Therapy, Highly Active; Antitubercular Agents; Clavulanic Acid; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Humans; Isoniazid; Linezolid; Mycobacterium bovis; Oxazolidinones; Thioacetazone; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2001 |
Amoxicillin-clavulanic acid for treating drug-resistant Mycobacterium tuberculosis.
Topics: Adult; Amoxicillin; Antitubercular Agents; beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Male; Mycobacterium tuberculosis; Tuberculosis, Pulmonary | 1991 |